Partnerships

>

Latest News

Darmstadt, Germany - November 10, 2021: A building at the headquarters of science and technology company Merck KGaA. | Image Credit: © Anne Czichos - stock.adobe.com
Simtra, MilliporeSigma Align to Provide ADC Drug Substance, Drug Manufacturing Services

June 11th 2025

The agreement, which covers a period of five years, has been designed to offer a turnkey service to companies seeking faster time to market for ADCs and bioconjugates.

robot arm moving plastic bottle to conveyor belt of auto capping and labeling machine at cosmetic and skin care manufacturing. cosmetic industry and ai technology machinery concept. | Image Credit: © gumpapa - stock.adobe.com
TriLink and Quantoom Ink License and Supply Agreement for mRNA Capping Technology

June 4th 2025

3d rendered illustration of platelets | Image Credit: © Sebastian Kaulitzki - stock.adobe.com
PL BioScience, DewCell Biotherapeutics to Develop Scalable Animal-Free Cell Culture Media

May 21st 2025

Image Credit: © Tiero - stock.adobe.com
Biotherapeutics Partnerships and Innovation Expanding

April 28th 2025

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept | Image Credit: © Dilok – © Dilok - stock.adobe.com
CN Bio and Pharmaron Partner to Develop OOC Technologies for Global R&D

April 26th 2025

More News

i4-145390-1408697500273.gif

The Human Side of Partnerships

Stuart Kliman;Larraine Segil;Laura Judy Visioni
October 1st 2004

He potential for frustration, time-wasting, and bad feelings between pharma and biotech partners is enormous. That some successful decisions are made under these circumstances is something of a miracle.

Site Logo

BioPartnering: Global BioPartnering: A Personal Perspective

Robert Lee Kilpatrick
May 1st 2004

Biotechnology players are emerging in countries that historically have not been substantially active in this industry.

Site Logo

Becoming a Partner of Choice and Evaluating Prospective Alliances

Jan Heybroek;David Wallis
February 15th 2003

by David Wallis, Dechert and Jan Heybroek Whether you're on the inlicensing or outlicensing side of a collaboration, attention must be paid to putting forth the right image and learning about your prospective partners before the alliance is struck.

<1
...
2425262728
© 2025 MJH Life Sciences

All rights reserved.